News | April 25, 2026
Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Move to accelerate cancer care expansion across India
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
Subscribe To Our Newsletter & Stay Updated
